Interleukin 2 News and Research

RSS
B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

A combined influenza and COVID-19 mRNA vaccine

A combined influenza and COVID-19 mRNA vaccine

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

New test can tell if you are immune to SARS-CoV-2

New test can tell if you are immune to SARS-CoV-2

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Superior T-cell immunity in COVID vaccinated

Superior T-cell immunity in COVID vaccinated

Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Combating COVID cytokine storm with targeted nucleic acid therapies

Combating COVID cytokine storm with targeted nucleic acid therapies

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

Immune responses in patients with varying degrees of SARS-CoV-2 infection

Immune responses in patients with varying degrees of SARS-CoV-2 infection

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Study shows enduring T-cell immunity up to at least 1-year after SARS-CoV-2 infection

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants

A common cold may boost the immune system against COVID-19

A common cold may boost the immune system against COVID-19